Presentation Information
[DVA-28]Development of anti-influenza drugs using host-directed antisense oligonucleotides
○Makoto Shimooka1, Tomomi Kirino1, Harumi Yamaguma2, Natsumi Kameoka2, Hina Miyazaki1, Itsuki Anzai1, Shintaro Shichinohe1, Satoshi Obika3,4,5,6, Yuuya Kasahara2,5, Tokiko Watanabe1,3,4 (1. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, 2. National Institutes of Biomedical Innovation, Health and Nutrition, 3. Center for Infectious Disease Education and Research, The University of Osaka, 4. Center for Advanced Modalities and DDS, The University of Osaka, 5. Graduate School of Pharmaceutical Sciences, The University of Osaka, 6. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka)